← Leaderboards
Grace E. Stutzmann
Rosalind Franklin Univ Of Medicine & Sci
$5,913,367
Attributed
$9,621,559
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2008–24$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,621,559 · 9
By mechanism
RF1$6,133,585 · 3
R01$1,821,454 · 2
R21$1,276,520 · 3
R56$390,000 · 1
Top collaborators
- Robert Anthony Marr2 shared
- Israel Sekler2 shared
- John K. Buolamwini1 shared
- Stephen D. Ginsberg1 shared
- Judith Potashkin1 shared
Most similar at Rosalind Franklin Univ Of Medicine & Sci
Same institution · by research overlap
- Daniel Tommis Christian$310,747
- Robert Anthony Marr$1,518,326
- Israel Sekler$1,074,370
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposNeuronsSignal TransductionSynapsesCellsSynaptic TransmissionTau ProteinsResponseImageImpaired CognitionFunctional DisorderPatch ClampPathologyPathogenesisAmyloidCalciumMouse ModelMediatingPropertyLinkS DiseaseBrainProteinsSlice
Grant awards (15)
Intracellular organelle deficits driving Alzheimer's disease$431,155
R01 · FY2024 · AG · contact PI
Septhohippocamal connectome dysfunction in Down syndrome associated with Alzheimerâs disease pathophysiology$2,466,001
RF1 · FY2023 · AG
Utilizing gene-level biomarkers of AD to identify pathophysiological mechanisms in human neurons$422,645
R21 · FY2023 · AG · contact PI
Intracellular organelle deficits driving Alzheimer's disease$1,717,584
RF1 · FY2020 · AG · contact PI
Cellular and synaptic signaling mechanisms driving early AD pathology$390,000
R56 · FY2018 · AG · contact PI
Novel Drug Discovery for AD Targeting Ryanodine Calcium Channels$1,950,000
RF1 · FY2016 · AG · contact PI
Validating novel ryanodine receptor-targeted compounds for AD therapeutics$195,000
R21 · FY2016 · AG · contact PI
Validating novel ryanodine receptor-targeted compounds for AD therapeutics$234,000
R21 · FY2015 · AG · contact PI
NMDA receptor plasticity in nucleus accumbens spines during cocaine withdrawal$193,125
R21 · FY2014 · DA · contact PI
NMDA receptor plasticity in nucleus accumbens spines during cocaine withdrawal$231,750
R21 · FY2013 · DA · contact PI
Neuronal Calcium Dysregulation in Aging and Alzheimer's disease$270,375
R01 · FY2012 · AG · contact PI
Neuronal Calcium Dysregulation in Aging and Alzheimer's disease$270,375
R01 · FY2011 · AG · contact PI
Neuronal Calcium Dysregulation in Aging and Alzheimer's disease$281,289
R01 · FY2010 · AG · contact PI
Neuronal Calcium Dysregulation in Aging and Alzheimer's disease$284,130
R01 · FY2009 · AG · contact PI
Neuronal Calcium Dysregulation in Aging and Alzheimer's disease$284,130
R01 · FY2008 · AG · contact PI